NCT00333827View on ClinicalTrials.gov

Cell Therapy In Dilated Cardiomyopathy

PHASE3CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2012

Study Completion Date

February 28, 2013

Conditions
Dilated Cardiomyopathy
Interventions
DRUG

optimal therapy for cardiaca failure

optimal therapy for cardiaca failure

PROCEDURE

cell

stem cell

Trial Locations (1)

22.240-006

INCL - National Institute of Cardiology Laranjeiras, Rio de Janeiro

All Listed Sponsors
collaborator

Financiadora de Estudos e Projetos

OTHER

lead

Ministry of Health, Brazil

OTHER_GOV

NCT00333827 - Cell Therapy In Dilated Cardiomyopathy | Biotech Hunter | Biotech Hunter